MAPK signaling pathway-targeted marine compounds in cancer therapy

被引:0
|
作者
Jiaen Wei
Ruining Liu
Xiyun Hu
Tingen Liang
Zhiran Zhou
Zunnan Huang
机构
[1] Guangdong Medical University,Key Laboratory of Big Data Mining and Precision Drug Design of Guangdong Medical University, Key Laboratory for Research and Development of Natural Drugs of Guangdong Province, School of Pharmacy
[2] Marine Medical Research Institute of Guangdong Zhanjiang,undefined
关键词
Marine compounds; MAPK signaling pathway; Anticancer drug discovery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 22
页数:19
相关论文
共 50 条
  • [41] VEGF Pathway-targeted Therapy for Advanced Renal Cell Carcinoma: A Meta-analysis of Randomized Controlled Trials
    刘飞
    陈先国
    彭鄂军
    管维
    李有元
    胡志全
    叶章群
    庄乾元
    [J]. Current Medical Science, 2011, 31 (06) : 799 - 806
  • [42] VEGF pathway-targeted therapy for advanced renal cell carcinoma: A meta-analysis of randomized controlled trials
    Fei Liu
    Xianguo Chen
    Ejun Peng
    Wei Guan
    Youyuan Li
    Zhiquan Hu
    Zhangqun Ye
    Qianyuan Zhuang
    [J]. Journal of Huazhong University of Science and Technology [Medical Sciences], 2011, 31 : 799 - 806
  • [43] Targeting the Ras-MAPK pathway for cancer therapy
    Luo, J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 14 - 14
  • [44] VEGF pathway-targeted therapy for advanced renal cell carcinoma: A meta-analysis of randomized controlled trials
    Liu, Fei
    Chen, Xianguo
    Peng, Ejun
    Guan, Wei
    Li, Youyuan
    Hu, Zhiquan
    Ye, Zhangqun
    Zhuang, Qianyuan
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2011, 31 (06) : 799 - 806
  • [45] The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
    Yuan, Jimin
    Dong, Xiaoduo
    Yap, Jiajun
    Hu, Jiancheng
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [46] The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
    Jimin Yuan
    Xiaoduo Dong
    Jiajun Yap
    Jiancheng Hu
    [J]. Journal of Hematology & Oncology, 13
  • [47] Effects of MAPK pathway inhibitors (AZD6244) on resistance of breast cancer cells to chemotherapy and targeted therapy
    Huang, Zhiqiang
    Wu, Hualian
    [J]. MATERIALS EXPRESS, 2023, 13 (01) : 54 - 60
  • [48] Pathway activation driven miRNA depletion highlights cancer signaling vulnerabilities and targeted therapy sensitivity
    Wurm, Alexander A.
    Brilloff, Silke
    Carrero, Zunamys I.
    Drukewitz, Stephan
    Krueger, Alexander
    Oster, Sandra
    Kolovich, Sofia
    Huether, Melanie
    Uhrig, Sebastian
    Westphal, Dana
    Meier, Friedegund
    Pfuetze, Katrin
    Huebschmann, Daniel
    Horak, Peter
    Kreutzfeldt, Simon
    Heining, Christoph
    Richter, Daniela
    Froehling, Stefan
    Ball, Claudia R.
    Glimm, Hanno
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [49] Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer
    Yabuuchi, Shinichi
    Pai, Shweta G.
    Campbell, Nathaniel R.
    de Wilde, Roeland F.
    De Oliveira, Elizabeth
    Korangath, Preethi
    Streppel, Mirte M.
    Rasheed, Zeshaan A.
    Hidalgo, Manuel
    Maitra, Anirban
    Rajeshkumar, N. V.
    [J]. CANCER LETTERS, 2013, 335 (01) : 41 - 51
  • [50] Deep Interrogation of Metabolism Using a Pathway-Targeted Click-Chemistry Approach
    Hoki, Jason S.
    Le, Henry H.
    Mellott, Karlie E.
    Zhang, Ying K.
    Fox, Bennett W.
    Rodrigues, Pedro R.
    Yu, Yan
    Helf, Maximilian J.
    Baccile, Joshua A.
    Schroeder, Frank C.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2020, 142 (43) : 18449 - 18459